Test Price
2,800 AED✅ Home Collection Available
PDE10A Gene Dyskinesia (Limb and Orofacial, Infantile-Onset) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test guidance by DHA-licensed Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PDE10A gene test screens for pathogenic variants causing severe infantile-onset limb and orofacial dyskinesia. This next-generation sequencing test enables precise diagnosis and informs targeted management strategies. Pre-test preparation includes detailed clinical history and genetic counselling to construct a pedigree chart of affected family members, ensuring accurate variant interpretation.
Acceptable Sample Types
- Peripheral whole blood (3–5 mL in EDTA tube)
- Extracted DNA (≥1 µg, high molecular weight)
- FTA card blood spot (one drop of blood)
| Feature | Our UAE Test | Common Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage | Single‑gene Sanger sequencing or limited panel |
| Turnaround Time | 3 to 4 Weeks (expedited available) | 6–8 Weeks or longer |
| Diagnostic Precision | >99.9% analytical sensitivity & specificity | Variable; may miss rare variants |
| Regulatory Compliance | DHA & MOHAP approved, ISO 9001:2015 | May lack UAE-specific licensing |
Physician Insight & Safety Protocols
"As a consultant clinical geneticist, I have seen how early and accurate molecular diagnosis of infantile-onset dyskinesia can transform management. This NGS test for PDE10A provides definitive results, but must always be interpreted in the full context of clinical history, examination, and family pedigree. I strongly recommend pre- and post-test genetic counselling to ensure families understand the implications."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Medication Warning
Do not discontinue or alter any prescribed medication without consulting your treating physician. Abrupt changes may worsen symptoms or trigger adverse effects.
Patient Safety & Exclusion Criteria
- Patients who received a blood transfusion within the last 7 days – donor DNA may interfere; reschedule sample collection after clearance.
- Severe acute febrile illness or systemic infection – postpone draw until clinical stability to avoid compromised sample quality.
Emergency Red Flags (Call 998 or visit ER immediately)
- Sudden onset of seizures, breathing difficulty, or loss of consciousness.
- Rapid worsening of dyskinesia leading to inability to feed, swallow, or protect airway.
Patient FAQ & Clinical Guidance
1. What exactly does the PDE10A gene test detect, and why is it important for my child?
This NGS test identifies disease-causing variants in the PDE10A gene linked to severe infantile-onset limb and orofacial dyskinesia, enabling a definitive diagnosis and guiding targeted clinical management.
2. How is the sample collected, and is home service available in the UAE?
A trained phlebotomist performs a simple blood draw using a cold‑chain kit, and VIP home collection is available across all Emirates from 8 AM to 11 PM, including weekends.
3. Will my insurance cover the cost of this genetic test?
Many UAE insurers cover clinically indicated genetic testing; our team verifies your policy directly via WhatsApp at +971545488731 and assists with pre‑approval documents.
4. How long does it take to get results, and who explains them?
Turnaround time is 3 to 4 weeks from sample receipt. A DHA-licensed Consultant Medical Genetics provides a telephonic post-test consultation to review the report and its clinical implications.
UAE Regulatory & Data Privacy Adherence
- Data Protection: Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Data Security: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient Safety & Consent: All clinical procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed consent and safe practice.
Clinical & Logistical Metadata
| Test Name | PDE10A Gene Dyskinesia (Limb and Orofacial, Infantile-Onset) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks (expedited available) |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card blood spot |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene coverage |
| ICD-10-CM Code | G25.8 |
| LOINC Code | 48808-2 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians